Form ARS - Annual Report to Security Holders:
SEC Accession No. 0001193125-23-180322
Filing Date
2023-06-30
Accepted
2023-06-30 15:33:51
Documents
1
Period of Report
2022-12-31
Effectiveness Date
2023-06-30

Document Format Files

Seq Description Document Type Size
1 ARS d409293dars.pdf ARS 1226820
  Complete submission text file 0001193125-23-180322.txt   1691304
Mailing Address CONNAUGHT HOUSE, 1ST FLOOR 1 BURLINGTON ROAD DUBLIN L2 4
Business Address CONNAUGHT HOUSE, 1ST FLOOR 1 BURLINGTON ROAD DUBLIN L2 4 011-353-1-772-2100
Horizon Therapeutics Public Ltd Co (Filer) CIK: 0001492426 (see all company filings)

EIN.: 000000000 | State of Incorp.: L2 | Fiscal Year End: 1231
Type: ARS | Act: 34 | File No.: 001-35238 | Film No.: 231061399
SIC: 2834 Pharmaceutical Preparations